SMTL ID : 7kg6.1

Structure of human PARG complexed with PARG-322

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.96 Å

Oligo State

monomer

Ligands

1 x WDG: 1-{2-[(1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)sulfanyl]ethyl}piperidine-4-carboxylic acid(Non-covalent)

WDG.1: 17 residues within 4Å: Chain A: T.280, I.281, E.282, F.293, V.308, Q.309, I.312, Y.347, Y.350, A.351, T.422, G.423, N.424, G.428, A.429, F.455, F.457 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:V.308 Hydrogen bonds: A:I.281 Water bridges: A:N.424 pi-Stacking: A:F.457, A:F.457

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Brosey, C.A. et al., Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors. Prog.Biophys.Mol.Biol. (2021)

Release Date

2021-03-10

Peptides

Poly(ADP-ribose) glycohydrolase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Poly(ADP-ribose) glycohydrolase

Related Entries With Identical Sequence